They extra they hope the a lot easier access to Zepbound will discourage persons from employing untested, knock-off medications to deal with obesity.Deep Dive Biotech’s M&A outlook is uncertain. Track the promotions which have been happening listed here. Billion-greenback biotech buyouts are becoming rarer. Only six on the acquisitions tracked by